Get the Stockscreener App
33.96
6.59%
2.10
After Hours:
33.83
-0.13
-0.38%
Hims Hers Health Inc stock is traded at $33.96, with a volume of 11.15M.
It is up +6.59% in the last 24 hours and up +34.92% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
See More
Previous Close:
$31.86
Open:
$32.18
24h Volume:
11.15M
Relative Volume:
0.72
Market Cap:
$7.42B
Revenue:
$1.24B
Net Income/Loss:
$101.26M
P/E Ratio:
77.18
EPS:
0.44
Net Cash Flow:
$149.62M
1W Performance:
+9.94%
1M Performance:
+34.92%
6M Performance:
+60.19%
1Y Performance:
+283.30%
1-Day Range:
$32.09
$34.35
1-Week Range:
$29.10
$34.35
52-Week Range:
$8.505
$35.02
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
33.96 | 7.42B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
167.41 | 389.78B | 84.35B | 15.48B | 15.47B | 6.28 |
|
UL
Unilever Plc Adr
|
58.30 | 144.19B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
90.89 | 74.26B | 20.11B | 2.87B | 3.40B | 3.49 |
|
KMB
Kimberly Clark Corp
|
130.85 | 43.42B | 20.06B | 2.55B | 2.51B | 7.55 |
|
KVUE
Kenvue Inc
|
21.72 | 41.64B | 15.46B | 1.06B | 1.40B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
March 14th Options Now Available For Hims & Hers Health (HIMS) - Nasdaq
Hims & Hers Stock Surges 69.2% in Three Months: What's Next? - Yahoo Finance
Hims & Hers Health, Inc. (HIMS) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Hims & Hers Hopes Super Bowl Commercial About Obesity Stands Apart From Pack of Snacks - AOL
Genesee Capital Advisors LLC Invests $889,000 in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers: Potential Risks Ahead, But Shorting May Be Premature (HIMS) - Seeking Alpha
Thinner Amid Gluttony? Hims & Hers Debut First SB Ads For Weight-Loss Drugs 01/29/2025 - MediaPost Communications
Thinner Amid Gluttony? Hims & Hers Debuts First SB Ads For Weight-Loss Drugs 01/29/2025 - MediaPost Communications
‘Incredibly irresponsible’: Hims Super Bowl ad downplays risks of compounded drugs - STAT
A Closer Look at Hims & Hers Health's Options Market Dynamics - Benzinga
Hims & Hers Health (NYSE:HIMS) Trading 5.7% HigherTime to Buy? - MarketBeat
Hims & Hers set for Super Bowl ad debut highlighting GLP-1 weight loss drugs - MM+M Online
Hims & Hers is making a massive bet on a Super Bowl ad this year - Yahoo Finance
Is Hims & Hers Health Stock a Buy? - AOL
Hims & Hers to air its first Super Bowl spot, promoting weight loss drugs - Ad Age
SG Americas Securities LLC Has $2.53 Million Stake in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers health COO Melissa Baird sells shares worth $1.99 million - MSN
(HIMS) Investment Analysis and Advice - Stock Traders Daily
Why Hims & Hers Health, Inc. (HIMS) Is Skyrocketing Now - Insider Monkey
Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $536,424.00 in Stock - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) CEO Sells $815,107.84 in Stock - MarketBeat
Melissa Baird Sells 67,687 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock - MarketBeat
Hims & Hers health chief commercial officer sells $536,424 in stock - MSN
Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $1,619,174.70 in Stock - MarketBeat
Hims & Hers CEO Andrew Dudum sells $815k in stock - MSN
Hims & Hers Health: A Stock to Trade or Own? - MSN
Hims & Hers health chief commercial officer sells $536,424 in stock By Investing.com - Investing.com South Africa
Hims & Hers health chief legal officer sells shares worth over $1.6 million - MSN
hims & hers CEO Andrew Dudum sells shares worth $438,184 - MSN
3 US Growth Companies With 17% Insider Ownership - Simply Wall St
Hims & Hers Health down as Citi downgrades on GLP-1 revenue stream overvaluation - MSN
hims & hers CEO Andrew Dudum sells shares worth $438,184 By Investing.com - Investing.com Nigeria
Hims & Hers Health's chief commercial officer sells $8,776 in stock - MSN
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors - MSN
Andrew Dudum Sells 36,460 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock - MarketBeat
S.F. doughnut shop owned by startup CEO faces backlash over his company’s $1 million Trump donation - San Francisco Chronicle
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Ultrasound Weight Loss: GE HealthCare and Novo Nordisk's Play - Benzinga
Hims & Hers shares rally as forecast bumped higher and more profitability said to be ahead - MSN
Hims & Hers CEO Andrew Dudum sells $2.27 million in stock - MSN
Hims & Hers CEO Andrew Dudum sells $2.27 million in stock By Investing.com - Investing.com South Africa
Hims & Hers Health Inc (HIMS) Shares Up 6.03% on Jan 21 - GuruFocus.com
Hims & Hers Health Unusual Options Activity - Benzinga
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Diversify Advisory Services LLC Has $1.02 Million Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health Stock Climbs Following Q4 Earnings Beat, Revenue Beat, Guidance Above Estimates - MSN
Hims & Hers: Ready To Outperform Further - Seeking Alpha
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):